Literature DB >> 580488

Clinical and laboratory aspects of disseminated intravascular coagulation (DIC): a study of 118 cases.

T Siegal, U Seligsohn, E Aghai, M Modan.   

Abstract

The medical records of 118 cases who met laboratory criteria of DIC were studied. The most frequent etiologies were: Generalized infection (39.8%), trauma (16.9%), malignancy (6.8%) and surgical cases (6.8%). The main clinical manifestations which appeared to be related solely to DIC were (in a decreasing order of frequency): Bleeding (64.4%), renal dysfunction (24.6%), liver dysfunction (18.6%), respiratory dysfunction (16.1%), shock (14.4%), thromboembolic phenonmena (6.8%) and central nervous system involvement (1.7%). In 26 patients none of these manifestations were observed. In patients with infection, liver and renal dysfunction were frequent and respiratory dysfunction rare, whereas in trauma cases, liver and renal dysfunctions were rare and respiratory dysfunction frequent. This variability indicates that the clinical manifestations are affected not only by the process of intravascular coagulation but also by the underlying clinical disorders. The most impaired coagulation tests were prothrombin time, partial thromboplastin time, platelet count and thrombin time. The degree of abnormality of these coagulation tests was found to be related to the extensiveness of organ involvement. The mortality (overall 54.7%) increased independently with age, with the number of clinical manifestations and with the degree of abnormality of the above-mentioned four most impaired coagulation tests. In addition, older patients were more likely to have an increased number of clinical manifestations and more impaired coagulation tests. Mortality was similar in the various etiologies except for trauma patients in whom it was lower (30%).

Entities:  

Mesh:

Year:  1978        PMID: 580488

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  18 in total

1.  Septic shock.

Authors:  M R Achong
Journal:  Can Fam Physician       Date:  1980-10       Impact factor: 3.275

2.  Association between necropsy evidence of disseminated intravascular coagulation and coagulation variables before death in patients in intensive care units.

Authors:  J T Wilde; K M Roberts; M Greaves; F E Preston
Journal:  J Clin Pathol       Date:  1988-02       Impact factor: 3.411

3.  Human platelet aggregation is initiated by peripheral blood mononuclear cells exposed to bacterial lipopolysaccharide in vitro.

Authors:  B S Schwartz; M C Monroe
Journal:  J Clin Invest       Date:  1986-11       Impact factor: 14.808

Review 4.  Disseminated intravascular coagulation: diagnosis and management.

Authors:  K L Saving
Journal:  Indian J Pediatr       Date:  1987 May-Jun       Impact factor: 1.967

5.  Blood Components Load in Post-operative Neurosurgical Patients Suspected with Disseminated Intravascular Coagulation.

Authors:  M Kotru; S S Munjal; M Singh; T Seth; H P Pati
Journal:  Indian J Hematol Blood Transfus       Date:  2017-01-09       Impact factor: 0.900

Review 6.  Disseminated intravascular coagulation: diagnosis and treatment.

Authors:  T Baglin
Journal:  BMJ       Date:  1996-03-16

7.  The current state of DIC.

Authors:  P E Hewitt; S C Davies
Journal:  Intensive Care Med       Date:  1983       Impact factor: 17.440

Review 8.  Obstructive sleep apnea syndrome: blood viscosity, blood coagulation abnormalities, and early atherosclerosis.

Authors:  Domenico Maurizio Toraldo; Francesco Peverini; Michele De Benedetto; Francesco De Nuccio
Journal:  Lung       Date:  2012-10-18       Impact factor: 2.584

9.  DIAGNOSING DISSEMINATED INTRAVASCULAR COAGULATION IN ACUTE INFECTION : CAN WE DO WITHOUT FDP & D-DIMER.

Authors:  M M Arora; K B Mishra; Velu Nair; J R Bhardwaj; Rajvir Bhalwar; B L Somani
Journal:  Med J Armed Forces India       Date:  2011-07-21

10.  Prothrombin time derived fibrinogen determination on Sysmex CA-6000.

Authors:  A S Lawrie; S J McDonald; G Purdy; I J Mackie; S J Machin
Journal:  J Clin Pathol       Date:  1998-06       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.